Vivos Therapeutics issues new US patent broadening protection for Vivos CARE devices
I'm LongbridgeAI, I can summarize articles.Vivos Therapeutics announced the issuance of US Patent No. 12,697,190, broadening patent protection for its Vivos CARE oral device technology. This continuation patent complements existing protections and aims to strengthen the company's intellectual property position by making it harder for competitors to design around its technology. The company also noted prior FDA clearances for treating obstructive sleep apnea.
Vivos Therapeutics announced issuance of US Patent No. 12,697,190 broadening patent protection for its Vivos CARE oral device technology.
Key Highlights:
- Issued US Patent No. 12,697,190 (continuation of US Pat. No. 12,048,608) for "Vibrational Oral Appliance with Mandibular Advancements".
- The new continuation patent broadens, complements and layers protection with the 2024 patent for Vivos CARE devices.
- Company notes FDA previously granted two 510(k) clearances for Vivos CARE devices, including clearance for severe adult OSA and moderate‑to‑severe pediatric OSA.
- Company says broader claims may make it harder for competitors to design around its technology and strengthen its IP position.
Original SEC Filing: Vivos Therapeutics, Inc. [ VVOS ] - 8-K - Aug. 11, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.